Showing results 165 to 184 of 458
< previous
next >
| Issue Date | Title | Author(s) |
| 2017-07-01 | Feasibility and Pilot Studies in Palliative Care Research: A Systematic Review | Jones, TA; Olds, TS; Currow, DC; Williams, MT |
| 2013-06-10 | Five years' time and the next five things for the list of choosing wisely | Currow, DC; Abernethy, AP |
| 2023-08-01 | Five-Year Trajectories of Prescription Opioid Use. | Gisev, N; Buizen, L; Hopkins, RE; Schaffer, AL; Daniels, B; Bharat, C; Dobbins, T; Larney, S; Blyth, F; Currow, DC; Wilson, A; Pearson, S-A; Degenhardt, L |
| 2011-04-01 | Former palliative caregivers who identify that additional spiritual support would have been helpful in a population survey | Hegarty, MM; Abernethy, AP; Olver, I; Currow, DC |
| 2012-03-01 | Gaps in the evidence base of opioids for refractory breathlessness. A future work plan? | Johnson, MJ; Abernethy, AP; Currow, DC |
| 2012-12-12 | Guidelines for a palliative approach for aged care in the community setting: A suite of resources | Toye, C; Blackwell, S; Maher, S; Currow, DC; Holloway, K; Tieman, J; Hegarty, M |
| 2022-04 | Handling Missing Data and Drop Out in Hospice/Palliative Care Trials Through the Estimand Framework. | Grobler, AC; Lee, KJ; Wong, A; Currow, DC; Braat, S |
| 2019-09-01 | Harms From Haloperidol for Symptom Management in Palliative Care—a Post Hoc Pooled Analysis of Three Randomized Controlled Studies and Two Consecutive Cohort Studies | Matsuoka, H; Agar, M; Vandersman, Z; Good, P; Fazekas, B; Brown, L; Hardy, J; Weil, J; Currow, DC |
| 2023-04 | Health care professionals' experiences of dealing with cancer cachexia. | Ellis, J; Petersen, M; Chang, S; Ingham, G; Martin, P; Morgan, N; Vaughan, V; Brown, L; Currow, DC; Razmovski-Naumovski, V |
| 2021-10-11 | Health service utilisation associated with chronic breathlessness: random population sample. | Currow, DC; Chang, S; Ekström, M; Hutchinson, A; Luckett, T; Kochovska, S; Hay, P; Touyz, S; Dal Grande, E; Johnson, MJ |
| 2020-10-31 | Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide. | McCaffrey, N; Asser, T; Fazekas, B; Muircroft, W; Agar, M; Clark, K; Eckermann, S; Lee, J; Joshi, R; Allcroft, P; Sheehan, C; Currow, DC |
| 2016-09-20 | Health-related quality of life measured using the EQ-5D-5L: South Australian population norms | McCaffrey, N; Kaambwa, B; Currow, DC; Ratcliffe, J |
| 2023-03 | Hiding in plain sight: the evolving definition of chronic breathlessness and new ICD-11 wording. | Kochovska, S; Ekström, M; Hansen-Flaschen, J; Ferreira, D; Similowski, T; Johnson, MJ; Currow, DC |
| 2023-03-14 | High-quality phase 3 studies do not support the use of somatostatin analogues to reduce vomiting in malignant bowel obstruction. | Boland, JW; Boland, EG; Currow, DC |
| 2011-06-01 | Hospital and emergency department use in the last year of life: A baseline for future modifications to end-of-life care | Rosenwax, LK; McNamara, BA; Murray, K; McCabe, RJ; Aoun, SM; Currow, DC |
| 2016-04-01 | How Accurately Do Consecutive Cohort Audits Predict Phase III Multisite Clinical Trial Recruitment in Palliative Care? | McCaffrey, N; Fazekas, B; Cutri, N; Currow, DC |
| 2019-07-01 | How Can Activity Monitors Be Used in Palliative Care Patients? | To, THM; Currow, DC; Swetenham, K; Morgan, DD; Tieman, J |
| 2021-09 | <i>Torschlusspanik</i>: A Not-so-Medieval Existential Construct. | Currow, DC; Jurgens, K |
| 2022-07-01 | Identifying barriers and facilitators of translating research evidence into clinical practice: A systematic review of reviews. | Abu-Odah, H; Said, NB; Nair, SC; Allsop, MJ; Currow, DC; Salah, MS; Hamad, BA; Elessi, K; Alkhatib, A; ElMokhallalati, Y; Bayuo, J; AlKhaldi, M |
| 2017-05-01 | Identifying factors that predict worse constipation symptoms in palliative care patients: A secondary analysis | Clark, K; Lam, LT; Talley, NJ; Phillips, JL; Currow, DC |
